Trial Profile
Phase I, Randomized, Placebo-Controlled Trial of Linaclotide to Demonstrate Colorectal Bioactivity in Health Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Nov 2022
Price :
$35
*
At a glance
- Drugs Linaclotide (Primary)
- Indications Irritable bowel syndrome
- Focus Biomarker; Pharmacodynamics
- 08 May 2018 Status changed from active, no longer recruiting to completed.
- 08 May 2018 Status changed from active, no longer recruiting to completed.
- 24 Jun 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2018 as reported by ClinicalTrials.gov.